National Retirement Planning Week: April 13-17

Wealth
Strategies

Help your clients retire on their terms by sharing these five tips to making the most out of retirement opportunities.
READ NOW

Barron’s recognizes the Janus Contrarian Fund as a “high-profile fund” that is “back on a market-beating course.” (4/4/2015)

Newly Reopened: A Risk-Conscious Small-Cap Fund — Morningstar (1/22/2015)

Andy Acker, PM of the Janus Global Life Sciences Fund, discusses his views in Fortune's article "The Science of Making Money in Biotech." (3/15/2015)

Named Best Mixed-Asset Target Allocation Moderate Fund over ten years (Class D shares)*

 Overall Morningstar Rating™
(as of 03/31/2015), Class D Shares, among 787 Moderate Allocation Funds.

FIND MY SALES DIRECTOR

Enter your ZIP code to get contact information for the wholesaler in your region.

ENTER ZIP:
SUBMIT   

If you are an RIA: CONTACT RIA GROUP

PORTFOLIO ANALYSIS TOOL

Test and analyze portfolio weaknesses and strengths with our Fund vs. Fund, Portfolio Analysis and Portfolio Comparison tools powered by Morningstar.

UPCOMING CONFERENCE CALLS

Building Meaningful Relationships with CPAs featuring John Evans Jr., Executive Director of Janus Labs & John Kuttin, Barron's top 100 advisor of 2014, CEO of Kuttin Consulting Group